Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial.

MLA

Griffin, Simon J., et al. “Effect of Early Intensive Multifactorial Therapy on 5-Year Cardiovascular Outcomes in Individuals with Type 2 Diabetes Detected by Screening (ADDITION-Europe): A Cluster-Randomised Trial.” Lancet (London, England), vol. 378, no. 9786, July 2011, pp. 156–67. EBSCOhost, https://doi.org/10.1016/S0140-6736(11)60698-3.

APA

Griffin, S. J., Borch-Johnsen, K., Davies, M. J., Khunti, K., Rutten, G. E. H. M., Sandbæk, A., Sharp, S. J., Simmons, R. K., van den Donk, M., Wareham, N. J., & Lauritzen, T. (2011). Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet (London, England), 378(9786), 156–167. https://doi.org/10.1016/S0140-6736(11)60698-3

Chicago

Griffin, Simon J, Knut Borch-Johnsen, Melanie J Davies, Kamlesh Khunti, Guy E H M Rutten, Annelli Sandbæk, Stephen J Sharp, et al. 2011. “Effect of Early Intensive Multifactorial Therapy on 5-Year Cardiovascular Outcomes in Individuals with Type 2 Diabetes Detected by Screening (ADDITION-Europe): A Cluster-Randomised Trial.” Lancet (London, England) 378 (9786): 156–67. doi:10.1016/S0140-6736(11)60698-3.